Saints is an investment firm dedicated to providing liquidity to investors in private companies. Saints formed its first fund in 2000, and was a pioneer as a direct secondary fund. Since 2000, Saints has provided liquidity to General Partners and their Limited Partners in Venture Capital and Private Equity funds, to founders and early employees of venture-capital backed companies, and to financial institutions (banks, hedge funds and corporations) who have portfolios of private investments that they have wanted to sell. Saints prides itself on being honest with sellers about pricing and ability to close as well as being flexible in structuring a transaction to meet the needs of a seller—our deals are often structured and can include loans, deferred payments and upside sharing.

Les Fildena sont de nouveaux comprimés destinés au traitement des troubles de l’érection (parfois appelés impuissance). Achetez Fildena à bas prix sur https://fildena-france.com en France. Le médicament Fildena fonctionne chez presque tous les patients masculins et est donc souvent et volontiers prescrit. Si vous suivez toutes les recommandations données dans le mode d’emploi et ne dépassez pas la dose, le comprimé ne causera aucun dommage.

With a track record of over 15 years and investments in over 200 companies, Saints is the oldest and one of the largest direct secondary investors. Our team’s years of experience and our knowledge in industries like business services, telecom equipment, aerospace, cleantech, and security give us the ability to help sellers across an array of assets and sectors.

Saints serves four types of sellers:

  • Founders and Early Employees
  • General Partners of Venture Capital and Private Equity Funds
  • Financial Institutions with Illiquid Securities
  • Limited Partners of Old Venture Capital Funds